Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation.
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback